Compare Novartis AG (NVS) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Unity Software Inc — how do they compare? Novartis AG trades at $139.5 (market cap $262.64B), while Unity Software Inc trades at $42.65 (market cap $18.81B). The key difference: Novartis AG is far larger — about 14× Unity Software Inc's market cap, and Novartis AG pays a 3.44% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals.
| NVS | U | |
|---|---|---|
Market Cap | $262.64B | $18.81B |
Sector | Health | Technology |
52-Week High | $168.62 | $49.47 |
52-Week Low | $121.80 | $17.13 |
Enterprise Value | $303.97B | $18.70B |
Dividend Yield | 3.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) is trading at $137.70, down 13.93% following significant clinical trial setbacks for del-desiran and pelacarsen. The stock shows bearish technical signals with support at $133-$136 and resistance at $140-$143. Fundamentally, the company maintains strong profitability with 74.74% gross margins and 22.5% net income margins, though recent pipeline failures have overshadowed solid financial performance.
While Novartis maintains strong financial fundamentals and reiterated 2025-2030 growth guidance, the recent clinical trial failures create near-term uncertainty. The stock faces pressure from pipeline setbacks but offers value at current levels for long-term investors willing to weather development risks. Analyst consensus remains cautious with 68% hold ratings.
Unity Software (U) trades at $42.75, up 2.62% with bullish technical signals and strong analyst support. The company shows improving fundamentals with revenue stabilizing around $1.8B and narrowing losses, though still reporting negative net income. Recent Q2 2026 earnings beat expectations, while institutional activity shows mixed positioning with some major funds increasing stakes. Technical indicators suggest bullish momentum with support at $41 and resistance at $44.
The outlook remains cautiously optimistic with 81% analyst buy ratings and $47.45 price target, representing 11% upside. Key opportunities include Vector platform growth and margin expansion, while risks center on sustained profitability challenges and competitive pressures in the gaming/ad tech space. Execution on strategic initiatives will be critical for stock performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
